...
首页> 外文期刊>Oncology reports >Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9
【24h】

Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9

机译:趋化因子受体7通过激活基质金属蛋白酶9增强细胞趋化性和转移性头颈部鳞状细胞癌的迁移

获取原文
获取原文并翻译 | 示例
           

摘要

The mechanisms leading to squamous cell carcinoma of head and neck (SCCHN) metastasis are not fully understood. Although evidence shows that the chemokine receptor 7 (CCR7) and its ligand CCL19 may regulate tumor dissemination, their role is not clearly defined in SCCHN. Matrix metalloproteinases break consisting of tissue barrier to the surrounding tissue invasion and metastasis by destroying the balance of matrix degradation of the basement membrane of tumor cells and extracellular matrix (ECM). We used chemotaxis and migration assays, western blotting, gelatin zymography, actin polymerization assay, immunofluorescence staining and immunohistochemical analysis to explore whether MMP-9 can be activated by CCL19 (CCR7's ligand) and its role in SCCHN. The experiments were performed in the metastatic SCCHN cell line PCI-37B after pre-incubation of the cells with CCL19 and SB-3CT (inhibitor of MMP-9). Our results demonstrated that CCR7 favors PCI-37B cell chemotaxis and migration, upregulation of MMP-9 protein and motivates the activity of MMP-9 protein, induces reorganization of the actin cytoskeleton and upregulation of MMP-9 protein. SB-3CT can block all these effects. Collectively, our data indicated that CCR7 regulates cell chemotaxis and migration via MMP-9 in metastatic SCCHN, and these results provide a basis for new strategies in preventing metastases of SCCHN.
机译:导致头颈部鳞状细胞癌(SCCHN)转移的机制尚不完全清楚。尽管有证据表明趋化因子受体7(CCR7)及其配体CCL19可能调节肿瘤的传播,但在SCCHN中尚不清楚其作用。基质金属蛋白酶通过破坏肿瘤细胞基底膜和细胞外基质(ECM)基质降解的平衡,打破了对周围组织浸润和转移的组织屏障。我们使用了趋化性和迁移分析,蛋白质印迹,明胶酶谱分析,肌动蛋白聚合分析,免疫荧光染色和免疫组化分析来研究MMP-9是否可以被CCL19(CCR7的配体)激活及其在SCCHN中的作用。在将细胞与CCL19和SB-3CT(MMP-9抑制剂)预孵育后,在转移性SCCHN细胞系PCI-37B中进行实验。我们的结果表明,CCR7有利于PCI-37B细胞趋化和迁移,MMP-9蛋白的上调并刺激MMP-9蛋白的活性,诱导肌动蛋白细胞骨架的重组和MMP-9蛋白的上调。 SB-3CT可以阻止所有这些影响。总体而言,我们的数据表明,CCR7通过转移性SCCHN中的MMP-9调节细胞趋化性和迁移,这些结果为预防SCCHN转移的新策略提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号